Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
2
×
new york blog main
abbvie
akcea therapeutics
allergan
amgen
anylam pharmaceuticals
biohaven
biotech
boston blog main
boston top stories
cardiomyopathy
cgpr
drugs
eli lilly
europe blog main
fda
inotersen
merck
migraine
national
neuropathy
new york
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
tegsedi
transthyretin amyloidosis
What
approved
2
×
fda
medicines
2
×
adults
ago
akcea
allergan
alnylam
amyloidosis
attr
available
battle
class
debilitating
disease
drug
genetic
migraine
monday
new
nod
oks
patients
pfizer
pill
rare
sets
transthyretin
treat
treatment
ubrelvy
ubrogepant
wins
year
Language
unset
Current search:
medicines
×
approved
×
" national top stories "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
